The investment bank reiterated its bullish $450 price target on Broadcom shares after hosting a meeting with the company’s CEO.
CVS is getting repriced and presents a compelling bullish setup into 2026
With CVS re-establishing forward guidance and offering a deeply discounted valuation, the balance of risk favors upside.
This biotech stock has plummeted over the past year. RBC sees big turnaround ahead
RBC’s $22 price target implies an upside of 74% for shares of Biohaven.
Netflix’s fourth-quarter results left the Street disappointed. Where analysts see the stock going
While analysts maintained their long-term bullish stance on Netflix, many also cut their price targets for the streamer.
Wednesday’s big stock stories: What’s likely to move the market in the next trading session
Stocks sold off on Tuesday as President Trump stepped up his rhetoric around Greenland and tariffs. The three major averages saw their worst day since October.
Deutsche Bank says the ‘honeymoon is over’ for AI
Artificial intelligence will undergo periods of disillusionment, dislocation and increasing distrust in 2026, the firm said.
The ‘trap doors’ to watch in the S&P 500 and Nasdaq as trade pressure mounts, according to the charts
Todd Gordon reveals the levels he’s watching in the market and how to hedge against a prolonged decline.
Where investors can find some reliable income as most U.S. assets see big selling pressure
Investors can turn to bonds and dividend stocks for income as they ride out the market volatility, experts said.
Danish pension fund to sell $100 million in Treasuries, citing ‘poor’ U.S. government finances
AkademikerPension’s move comes amid increasing tensions with the U.S. over Greenland.
These safe stocks could ride out any extended market sell-off
As U.S. markets take a big hit with the chance of more turmoil ahead, certain stocks could be a bastion of safety for investors given their low volatility.